当前位置:首页 - 行情中心 - 国药股份(600511) - 财务分析 - 现金流量表

国药股份

(600511)

  

流通市值:159.03亿  总市值:216.84亿
流通股本:5.53亿   总股本:7.55亿

现金流量表

报告期2025-12-312025-09-302025-06-302025-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金56,483,077,866.2739,821,987,410.3125,805,029,245.7711,993,189,120.86
  收到的税费返还666,271.29588,977.41588,977.41575,688.96
  收到其他与经营活动有关的现金841,752,743.23368,254,545.51296,098,385.5114,925,050.64
  经营活动现金流入小计57,325,496,880.7940,190,830,933.2326,101,716,608.6812,108,689,860.46
  购买商品、接受劳务支付的现金51,550,999,642.439,468,754,090.5326,061,155,569.1613,202,038,549.76
  支付给职工以及为职工支付的现金854,542,592.38626,161,020.19425,224,768.79243,185,245.23
  支付的各项税费1,771,229,006.981,128,095,920.77803,866,224.99401,871,352.89
  支付其他与经营活动有关的现金1,143,208,126.971,018,252,683.85321,904,882.54154,770,431.48
  经营活动现金流出小计55,319,979,368.7342,241,263,715.3427,612,151,445.4814,001,865,579.36
  经营活动产生的现金流量净额2,005,517,512.06-2,050,432,782.11-1,510,434,836.8-1,893,175,718.9
二、投资活动产生的现金流量:
  收回投资收到的现金18,329,499.933,139,870.643,139,870.643,139,870.64
  取得投资收益收到的现金32,273,886.7829,327,149.229,327,149.2-
  处置固定资产、无形资产和其他长期资产收回的现金净额202,302.2578,328.6335,28035,080
  投资活动现金流入小计50,805,688.9632,545,348.4732,502,299.843,174,950.64
  购建固定资产、无形资产和其他长期资产支付的现金68,194,378.1740,419,863.9420,579,477.27,353,156.13
  投资活动现金流出小计68,194,378.1740,419,863.9420,579,477.27,353,156.13
  投资活动产生的现金流量净额-17,388,689.21-7,874,515.4711,922,822.64-4,178,205.49
三、筹资活动产生的现金流量:
  取得借款收到的现金319,447,721.2319,447,721.2160,000,000100,000,000
  筹资活动现金流入小计319,447,721.2319,447,721.2160,000,000100,000,000
  偿还债务支付的现金923,448,321.92636,348,932.49435,834,964.5168,409,692.67
  分配股利、利润或偿付利息支付的现金653,281,757.75644,787,849.53618,447,171.448,763,561.7
  其中:子公司支付给少数股东的股利、利润27,543,689.5124,433,001.583,920,214.07-
  支付其他与筹资活动有关的现金130,194,249.04114,391,693.1877,442,297.7149,359,766.2
  筹资活动现金流出小计1,706,924,328.711,395,528,475.21,131,724,433.65226,533,020.57
  筹资活动产生的现金流量净额-1,387,476,607.51-1,076,080,754-971,724,433.65-126,533,020.57
五、现金及现金等价物净增加额600,652,215.34-3,134,388,051.58-2,470,236,447.81-2,023,886,944.96
  加:期初现金及现金等价物余额8,291,394,056.968,291,394,056.968,291,394,056.968,291,394,056.96
  期末现金及现金等价物余额8,892,046,272.35,157,006,005.385,821,157,609.156,267,507,112
补充资料:
  净利润2,089,403,586-991,483,406.86-
  资产减值准备5,563,843.29-8,207,322.15-
  固定资产和投资性房地产折旧73,297,846.2-35,900,835.86-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧73,297,846.2-35,900,835.86-
  无形资产摊销54,366,923.24-27,273,148.39-
  长期待摊费用摊销10,067,575.5-5,648,711.51-
  处置固定资产、无形资产和其他长期资产的损失-212,185.96--548.56-
  固定资产报废损失102,985.11-102,830.57-
  公允价值变动损失-66,164.34---
  财务费用27,165,852.32-14,966,586.59-
  投资损失-585,314,905.57--293,601,361.38-
  递延所得税-20,566,368.53--16,264,245.5-
  其中:递延所得税资产减少-14,177,873.67--12,065,726.92-
    递延所得税负债增加-6,388,494.86--4,198,518.58-
  存货的减少-240,873,051.48--349,381,141.6-
  经营性应收项目的减少-692,570,321.85--2,066,194,870.11-
  经营性应付项目的增加1,140,496,132.06-17,549,011.2-
  其他--2,888,532.64-
  现金的期末余额8,892,046,272.3-5,821,157,609.15-
  减:现金的期初余额8,291,394,056.96-8,291,394,056.96-
  现金及现金等价物的净增加额600,652,215.34--2,470,236,447.81-
公告日期2026-03-202025-10-222025-08-212025-04-25
审计意见(境内)标准无保留意见
TOP↑